NASDAQ$BCPC
Balchem Corporation · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Balchem reported a solid Q4 2023, marked by record adjusted EBITDA and strong free cash flow, despite demand challenges in some areas. The Human Nutrition and Health segment achieved record sales and earnings.
Balchem Corporation reported Q4 2023 results with net sales of $228.7 million, net earnings of $26.6 million, adjusted EBITDA of $55.4 million, and free cash flow of $56.0 million. The Human Nutrition and Health segment had record sales and earnings.
- GAAP net earnings increased by 24.5% year-over-year to $26.6 million.
- Adjusted EBITDA increased by 5.4% year-over-year to $55.4 million.
- Record free cash flow of $56.0 million, up 103.4% from the prior year quarter.
- Record Human Nutrition & Health segment sales of $138.0 million, up 5.8% year-over-year, with record earnings from operations of $25.2 million, up 43.8%.
Headline financials
Revenue & EPS history
Balchem · Revenue · Quarterly
$229M
Revenue by segment
Balchem · $228M total across 3 segments · Q3 2023
- Human Nutrition & Health$144M+1.3%63.2%
- Animal Nutrition & Health$53.9M-17.8%23.6%
- Specialty Products$30M+1.2%13.1%
Forward guidance
Balchem is well positioned to deliver top and bottom line growth on a full year basis, while continuing to advance strategic growth initiatives.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
+0.0%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+0.9%
Avg return
30 days after
52%
34 / 65 earnings
Positive
+25.0%
Q1 2014
Best reaction
-16.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.8% | -7.0% | -9.7% | |
| Q4 2025 | -2.3% | +2.6% | -7.4% | |
| Q3 2025 | +4.1% | +3.9% | +1.3% | |
| Q1 2025 | -2.6% | -1.5% | +4.8% | |
| Q4 2024 | +1.5% | +7.0% | -0.1% | |
| Q3 2024 | +2.8% | +1.6% | +9.8% | |
| Q2 2024 | +3.9% | +1.5% | -1.2% | |
| Q1 2024 | -1.8% | -3.0% | -8.8% | |
| Q4 2023 | +7.4% | +5.0% | +6.8% | |
| Q3 2023 | -5.0% | -4.1% | +1.1% | |
| Q2 2023 | +4.8% | +5.0% | +7.1% | |
| Q1 2023 | +1.7% | +0.5% | +5.2% | |
| Q4 2022 | -2.0% | -0.2% | -7.7% | |
| Q3 2022 | -0.6% | -0.5% | +5.4% | |
| Q2 2022 | -5.2% | -6.6% | +2.3% | |
| Q1 2022 | +1.6% | -0.9% | -10.5% | |
| Q4 2021 | +1.0% | -0.7% | +1.2% | |
| Q3 2021 | -0.8% | +2.3% | +7.9% | |
| Q2 2021 | -0.8% | -2.5% | +2.7% | |
| Q1 2021 | -0.2% | -0.1% | +0.5% | |
| Q4 2020 | +5.4% | +6.4% | +10.7% | |
| Q3 2020 | -1.7% | -0.5% | +3.3% | |
| Q2 2020 | +4.6% | +4.7% | +0.3% | |
| Q1 2020 | -5.4% | -3.9% | -9.3% | |
| Q4 2019 | -10.7% | -13.3% | -15.9% | |
| Q3 2019 | +2.9% | +1.2% | -0.8% | |
| Q2 2019 | -16.3% | -15.9% | -13.5% | |
| Q1 2019 | +1.1% | +4.0% | +9.4% | |
| Q4 2018 | +8.0% | +12.4% | +10.7% | |
| Q3 2018 | -4.9% | -4.9% | -13.7% | |
| Q2 2018 | +1.1% | +1.3% | +10.1% | |
| Q1 2018 | -1.3% | +2.2% | +7.9% | |
| Q4 2017 | +2.3% | +5.9% | +8.6% | |
| Q3 2017 | +1.0% | -0.7% | +1.3% | |
| Q2 2017 | -2.6% | -3.9% | -1.8% | |
| Q1 2017 | -3.3% | -5.3% | -1.8% | |
| Q4 2016 | +5.2% | +2.2% | -2.5% | |
| Q3 2016 | -4.5% | +0.8% | +12.3% | |
| Q2 2016 | +1.3% | +2.0% | +8.7% | |
| Q1 2016 | +0.3% | — | — | |
| Q4 2015 | -0.4% | — | — | |
| Q3 2015 | -2.0% | — | — | |
| Q2 2015 | +5.2% | — | — | |
| Q1 2015 | -0.5% | — | — | |
| Q4 2014 | -3.4% | — | — | |
| Q3 2014 | +6.7% | — | — | |
| Q2 2014 | +2.5% | — | — | |
| Q1 2014 | +25.0% | — | — | |
| Q4 2013 | +0.4% | — | — | |
| Q3 2013 | -4.9% | — | — | |
| Q2 2013 | +1.3% | — | — | |
| Q1 2013 | -2.3% | — | — | |
| Q4 2012 | +0.8% | — | — | |
| Q3 2012 | -10.5% | — | — | |
| Q2 2012 | +5.9% | — | — | |
| Q1 2011 | +2.1% | — | — | |
| Q4 2011 | +2.1% | — | — | |
| Q1 2012 | +2.4% | — | — | |
| Q1 2010 | -4.1% | — | — | |
| Q4 2009 | -4.1% | — | — | |
| Q3 2010 | -3.2% | — | — | |
| Q3 2011 | -3.2% | — | — | |
| Q2 2011 | +1.0% | — | — | |
| Q4 2010 | +1.0% | — | — | |
| Q2 2010 | +1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro